These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37215719)

  • 1. Skin infiltrating T-cell profile of drug reaction with eosinophilia and systemic symptoms (DRESS) reactions among HIV-infected patients.
    Chimbetete T; Choshi P; Pedretti S; Porter M; Roberts R; Lehloenya R; Peter J
    Front Med (Lausanne); 2023; 10():1118527. PubMed ID: 37215719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced human immunodeficiency virus (HIV) does not affect ability to utilize lymphadenopathy in assessment of drug reaction with eosinophilia and systemic symptoms syndrome in HIV and tuberculosis: Prospective comparative study.
    Machona MS; Muloiwa R; Porter M; Peter J; Lehloenya RJ
    J Allergy Clin Immunol Glob; 2024 Aug; 3(3):100276. PubMed ID: 38946893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line anti-tuberculosis drug challenge reactions in DRESS in an HIV endemic setting.
    Porter M; Smith R; Teixeira N; Thwala B; Choshi P; Phillips EJ; Meintjes G; Dlamini S; Peter J; Lehloenya R
    J Allergy Clin Immunol Pract; 2024 Jun; ():. PubMed ID: 38852619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin-Homing IL-13-Producing T Cells Expand in the Circulation of Patients with Drug Rash with Eosinophilia and Systemic Symptoms.
    Teraki Y; Fukuda T
    Dermatology; 2017; 233(2-3):242-249. PubMed ID: 28601883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed CD4⁺ T cells.
    Yang C; Mosam A; Mankahla A; Dlova N; Saavedra A
    J Am Acad Dermatol; 2014 Jun; 70(6):1096-102. PubMed ID: 24629995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of human herpes virus 6 receptor CD134/OX40 in skin lesions of patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Lee ES; Kiuchi Y; Inomata N; Sueki H
    J Dermatol; 2023 Mar; 50(3):387-392. PubMed ID: 36121111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term HIV and tuberculosis outcomes in patients hospitalised with severe cutaneous adverse reactions.
    Veenstra S; Porter MN; Thwala BN; Pillay N; Panieri MA; van der Westhuizen J; Phillips EJ; Meintjes G; Dlamini S; Lehloenya RJ; Peter J
    J Clin Tuberc Other Mycobact Dis; 2023 Aug; 32():100374. PubMed ID: 37214159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
    Miyagawa F; Asada H
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased ratio of FoxP3+ regulatory T cells/CD3+ T cells in skin lesions in drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms.
    Morito H; Ogawa K; Fukumoto T; Kobayashi N; Morii T; Kasai T; Nonomura A; Kishimoto T; Asada H
    Clin Exp Dermatol; 2014 Apr; 39(3):284-91. PubMed ID: 24635062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic patch testing following tuberculosis-associated cutaneous adverse drug reactions induces systemic reactions in HIV-infected persons.
    Lehloenya RJ; Todd G; Wallace J; Ngwanya MR; Muloiwa R; Dheda K
    Br J Dermatol; 2016 Jul; 175(1):150-6. PubMed ID: 26918554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response.
    Picard D; Janela B; Descamps V; D'Incan M; Courville P; Jacquot S; Rogez S; Mardivirin L; Moins-Teisserenc H; Toubert A; Benichou J; Joly P; Musette P
    Sci Transl Med; 2010 Aug; 2(46):46ra62. PubMed ID: 20739682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review.
    Taweesedt PT; Nordstrom CW; Stoeckel J; Dumic I
    Biomed Res Int; 2019; 2019():7863815. PubMed ID: 31662996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interferon-γ-induced protein 10/CXCR3 axis is associated with human herpesvirus-6 reactivation and the development of sequelae in drug reaction with eosinophilia and systemic symptoms.
    Yang CW; Cho YT; Hsieh YC; Hsu SH; Chen KL; Chu CY
    Br J Dermatol; 2020 Nov; 183(5):909-919. PubMed ID: 32037509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological Characterization of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) and Comparison with Maculopapular Drug Rash (MPDR).
    Jindal R; Chugh R; Chauhan P; Shirazi N; Bisht YS
    Indian Dermatol Online J; 2022; 13(1):32-39. PubMed ID: 35198465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases.
    Walsh S; Diaz-Cano S; Higgins E; Morris-Jones R; Bashir S; Bernal W; Creamer D
    Br J Dermatol; 2013 Feb; 168(2):391-401. PubMed ID: 23034060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between tuberculin skin test reactivity, the memory CD4 cell subset, and circulating FoxP3-expressing cells in HIV-infected persons.
    Sarrazin H; Wilkinson KA; Andersson J; Rangaka MX; Radler L; van Veen K; Lange C; Wilkinson RJ
    J Infect Dis; 2009 Mar; 199(5):702-10. PubMed ID: 19199536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Biomarker Identification by RNA-Seq Analysis in Antibiotic-Related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Pilot Study.
    Teo YX; Haw WY; Vallejo A; McGuire C; Woo J; Friedmann PS; Polak ME; Ardern-Jones MR
    Toxicol Sci; 2022 Aug; 189(1):20-31. PubMed ID: 35703984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug reaction with eosinophilia and systemic symptoms related to antiretroviral treatment in human immunodeficiency virus patients.
    Brandariz D; Smithson A; Anton-Vazquez V
    Indian J Sex Transm Dis AIDS; 2017; 38(2):163-170. PubMed ID: 30148271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study.
    Sandhu S; Neema S; Vashisht D; Venugopal R; Sengupta P; Radhakrishnan S
    Dermatol Ther; 2021 Jan; 34(1):e14670. PubMed ID: 33314590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RegiSCAR DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) Validation Scoring System and Japanese Consensus Group Criteria for Atypical Drug-Induced Hypersensitivity Syndrome (DiHS): A Comparative Analysis.
    Sasidharanpillai S; Ajithkumar K; Jishna P; Khader A; Anagha KV; Binitha MP; Chathoth AT
    Indian Dermatol Online J; 2022; 13(1):40-45. PubMed ID: 35198466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.